La chaîne d'options affiche les données clés des options sur actions de Corbus Pharmaceuticals à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Corbus Pharmaceuticals..

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock, Chaîne d'Options

CORBUS PHARMACEUTICALS HOLDI

Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Billionaire investor Ray Dalio warned on Wednesday that President Donald Trump's latest round of tariffs could deepen "stagflation" and may never deliver on promises to revive U.S. factory floors.
What Happened: "The tariffs are being put into place as a symptom of things that are changing that will be there anyway," the Bridgewater Associates founder said in a video on X.
Dalio said the White House hopes levies will raise revenue and "develop manufacturing, which the United States needs both for employment reasons and security reasons." But he cast doubt on that outcome. "There is a belief that tariffs will bring manufacturing back to the United States, I am uncertain of that."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I've gotten a lot of questions on the recent Trump tariffs and their impact on the global economy. There is a belief that tariffs will bring manufacturing back to the United States, I am uncertain of that. You can learn more about why, and what the current big debt cycle the… <a href="https://t.co/GRlP1kiAOG">pic.twitter.com/GRlP1kiAOG</a>
&mdash; Ray Dalio (@RayDalio) <a href="https://twitter.com/RayDalio/status/1942969885924925615?ref_src=twsrc%5Etfw">July 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The hedge-fund manager argued the world is shifting from decades of free-flowing capital and goods to "a more controlled world" where production is no longer done by the most efficient producer. "That creates less efficiency in the goods and services markets … and in the capital markets," he said, adding the result is "higher inflation and slower growth — more stagflation."
See also: <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/07/46338091/dave-ramsey-tells-debt-laden-28-year-old-to-skip-courthouse-wedding-youll-tell-this-story-forever">Dave Ramsey Tells Debt-Laden 28-Year-Old To Skip Courthouse Wedding: &#8216;You&#8217;ll Tell This Story&#8217; Forever</a>
Why It Matters: Dalio's view echoes recent <a href="https://www.jpmorgan.com/insights/global-research/current-events/us-tariffs">forecasts</a> from J.P. Morgan and the OECD showing tariff-driven supply shocks shaving more than a point off <a href="https://www.oecd.org/en/about/news/press-releases/2025/06/global-economic-outlook-shifts-as-trade-policy-uncertainty-weakens-growth.html">global growth</a> next year. 
Trump's "reciprocal tariffs," which could reach 70% on some imports, are already rattling markets. Investors fear a replay of 2018's trade war, analysts <a href="https://www.theaustralian.com.au/subscribe/news/1/?sourceCode=TAWEB_WRE170_a&amp;dest=https%3A%2F%2Fwww.theaustralian.com.au%2Fbusiness%2Fmarkets%2Ftrumps-tariff-gambit-puts-investors-on-edge-as-deadline-looms%2Fnews-story%2Ff6f04a89069fe2b1aabc5080bafabacc&amp;memtype=anonymous&amp;mode=premium&amp;v21=GROUPB-Segment-2-NOSCORE&amp;V21spcbehaviour=append">told</a> The Australian. Harvard economists estimate the April round alone could trim U.S. GDP by <a href="https://hbr.org/2025/04/understanding-the-global-macroeconomic-impacts-of-trumps-tariffs">1.4 percentage points</a> in 2025.
Dalio has been sounding alarms for months, telling his X followers that <a href="https://www.benzinga.com/personal-finance/25/05/45249352/ray-dalio-says-its-too-late-to-escape-tariff-damage-worries-u-s-will-be-bypassed">tariffs are "too late"</a> to fix de-globalization and risk leaving the U.S. "bypassed by the rest of the world." He&#8217;s also pointed out that the ballooning federal debt plus higher import costs will trigger "<a href="https://www.benzinga.com/markets/guidance/25/07/46266299/ray-dalio-forecasts-big-painful-disruptions-as-us-national-debt-set-to-swell-over-next-decade">big, painful disruptions</a>."
Trump argues import taxes will bankroll domestic tax cuts and force trading partners to negotiate. Yet critics say higher prices for inputs like steel already threaten U.S. exporters. Dalio called the policy shift "theoretical" and said whether it truly boosts American factories "is still a question mark."
Read next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46337754/jim-cramer-says-a-tax-provision-in-trumps-one-big-beautiful-bill-could-gut-professional-gambling-heres-why-draftkings-fanduel-dont-mind">Jim Cramer Says A Tax Provision In Trump&#8217;s &#8216;One Big, Beautiful Bill&#8217; Could Gut Professional Gambling: Here&#8217;s Why DraftKings, FanDuel Don&#8217;t Mind</a></li>
</ul>
Image via Shutterstock

Government

News

Economics

General

Ray Dalio Says Trump's Tariffs Are 'Theoretical,' Warns They May Not Bring Manufacturing Back To US

Wolfe Research analyst Steven Chubak upgrades Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) from Peer Perform to Outperform and announces $339 price target.

Upgrades

Price Target

Analyst Ratings

PIPR

Wolfe Research Upgrades Piper Sandler to Outperform, Announces $339 Price Target

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">FY 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Earnings Per Share</td>
<td colspan="1" rowspan="1">$5.25 - $6.25</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Free Cash Flow ($B)</td>
<td colspan="1" rowspan="1">$3 - $4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gross Leverage2</td>
<td colspan="1" rowspan="1">Less than 2.5x</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Delta Air Lines Restores Its FY2025 Guidance: Sees Adj EPS $5.25-$6.25 vs $5.42 Est; Sees Free Cash Flow Of $3B-$4B

Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) is looking for Q3 Adj EPS of $1.25-$1.75 vs $1.34 analyst estimate..

Delta Air Lines Sees Q3 Adj EPS $1.25-$1.75 vs $1.34 Est; Revenue Expected To Increase 0%-4% YoY

HC Wainwright &amp; Co. analyst Sean Lee maintains Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) with a Buy and raises the price target from $2 to $13.

KZIA

HC Wainwright & Co. Maintains Buy on Kazia Therapeutics, Raises Price Target to $13

Trilogy Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TMQ#AMEX">TMQ</a>) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year.

Earnings

Trilogy Metals Q2 EPS $(0.01), Inline

HC Wainwright &amp; Co. analyst Mike Colonnese downgrades Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) from Buy to Sell and lowers the price target from $305 to $300.

Downgrades

COIN

HC Wainwright & Co. Downgrades Coinbase Global to Sell, Lowers Price Target to $300

Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) reported quarterly earnings of $2.10 per share which beat the analyst consensus estimate of $2.05 by 2.49 percent. This is a 11.02 percent decrease over earnings of $2.36 per share from the same period last year. The company reported quarterly sales of $16.65 billion which beat the analyst consensus estimate of $15.45 billion by 7.76 percent. This is a 0.06 percent decrease over sales of $16.66 billion the same period last year.

Earnings Beats

Delta Air Lines Q2 Adj. EPS $2.10 Beats $2.05 Estimate, Sales $16.65B Beat $15.45B Estimate

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Americas Gold And Silver (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/USAS#AMEX">USAS</a>) with a Buy and raises the price target from $1 to $1.3.

USAS

HC Wainwright & Co. Maintains Buy on Americas Gold And Silver, Raises Price Target to $1.3

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.
President Donald Trump imposed<a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46334793/trump-sends-lula-a-letter-imposing-50-tariffs-calls-bolsonaro-trial-a-witch-hunt-brazils-president-hits-back-will-not-accept-any-form-of-tutelage"> 50% tariffs on Brazil</a>, escalating the trade tensions between the two nations. This was followed by a slew of letters posted on his Truth Social account to Japan, South Korea, and other countries, with a deadline of making a deal by Aug. 1.
Trump also urged the Federal Reserve to cut interest rates by 3%, while <a href="https://www.benzinga.com/news/politics/25/07/46336115/as-trump-calls-for-3-percentage-point-rate-cut-too-late-jerome-powell-to-resign-june-fed-minutes-sh">June&#8217;s Fed minutes</a> were awash with words &#8220;uncertain&#8221; and &#8220;uncertainty,&#8221; over the tariffs.
The 10-year Treasury bond yielded 4.35% and the two-year bond was at 3.85%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool&#8217;s</a> projections show markets pricing a 93.3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its July meeting.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.23%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.17%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.16%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.15%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Thursday. The SPY was down 0.13% at $623.24, while the QQQ declined 0.086% to $555.77, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Information technology, utilities, and communication services stocks led the gains on Wednesday, driving U.S. stocks higher.
Investors largely overlooked fresh trade uncertainty, encouraged by the White House&#8217;s delay of new tariffs to Aug. 1st and renewed hopes for negotiations.
In contrast, energy and consumer staples stocks bucked the broader market trend, ending the session in the red.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) once again dominated headlines, reaching a staggering <a href="https://www.benzinga.com/markets/market-summary/25/07/46328569/wall-street-today-tariffs-nvidia-4-trillion">$4 trillion market capitalization</a> and cementing its position as the world&#8217;s most valuable company. It plans to introduce a new AI chip specifically for the Chinese market as early as September.
On the economic data front, U.S. wholesale inventories saw a 0.3% month-over-month decline in May, falling to $905.5 billion, which was consistent with preliminary estimates and followed a 0.1% increase in the prior month.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.94%</td>
<td>20,611.34</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.61%</td>
<td>6,263.26</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.49%</td>
<td>44,458.30</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.07%</td>
<td>2,252.49</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
The senior global market strategist at Wells Fargo, Scott Wren, highlighted that the resurfaced tariff negotiations after a 90-day pause have again started to impact global stock and bond markets.
He said that &#8220;Some potentially serious trade frictions were just around the corner, ready to rear their ugly heads and impact global stock and bond markets.&#8221;
Wren highlighted that the first 90-day pause of largely reciprocal tariffs with a number of important trading partners was due to expire today, July 9. But as the financial markets woke up and got ready to go on Monday morning, the headlines hit the newswires that the pause was being pushed back to Aug. 1, and letters were going out to various trading partners encouraging them to come to an agreement with the U.S. by this new date.
&#8220;The upcoming expiration of the 90-day tariff pause on Aug. 12 with China are just a big reminder that we are still in the early stages of hammering out what U.S. trade relationships with our largest global trade partners will be,&#8221; he said.
Granted, the magnitude of implementation has been uneven and inconsistent in recent months, Wren said that &#8220;U.S. consumers have yet to see the full effect of tariffs at this point.&#8221;
&#8220;Consumers are in many cases buying goods that were inventoried by sellers prior to the application of tariffs. Once those inventories are depleted and are replaced with goods that are subject to tariffs, we would expect to see goods inflation increase into the end of this year and in the early months of 2026,&#8221; he said.
Wren added that &#8220;Rising inflation is likely to increase market worries as market consensus calls for two rate cuts in 2025.&#8221;
Meanwhile, talking about inflation, Louis Navellier of Navellier &amp; Associates stated that &#8220;I am expecting favorable inflation reports and for retail sales to have picked up a bit from May's slow pace.&#8221;
&#8220;Economic activity appears to be picking up, so both business and consumer sentiment should be rising,&#8221; he added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Thursday:
<ul class="wp-block-list">
<li>Initial jobless claims data for the week ended July 5 will all be out by 8:30 a.m. ET.</li>
<li>St Louis Fed President Alberto Musalem will speak at 10:00 a.m., and San Francisco Fed President Mary Daly will speak at 2:30 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) rose 0.71% in premarket on Thursday after scaling a record market capitalization of over $4 trillion on Wednesday.</li>
<li>WK Kellogg Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>) zoomed 52.86% on a report that Ferrero is nearing an agreement to buy the breakfast food company for about $3 billion.</li>
<li>Klotho Neurosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) surged 54.74% as the company was granted FDA Orphan Drug designation for KLTO-202 for the treatment of amyotrophic lateral sclerosis.</li>
<li>Creative Medical Technology Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELZ#NASDAQ">CELZ</a>) tumbled 27% as it received a notice of allowance for a U.S. patent titled "Treatment Of Heart Failure And/Or Post Infarct Pathological Remodeling By Ex Vivo Reprogrammed Immune Cells."</li>
<li>Methode Electronics Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) dropped 14.29% after the company reported a fourth-quarter adjusted EPS miss.</li>
<li>AZZ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) was 0.60% higher after posting better-than-expected earnings for its first quarter, while sales missed estimates. The company raised its FY2026 adjusted EPS guidance from $5.50-$6.10 to $5.75-$6.25.</li>
<li>Kraft Heinz Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) was up 0.53% after it agreed to sell its infant and specialty food business in Italy to NewPrinces S.p.A.</li>
<li>Conagra Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) was up 0.79% as analysts expect it to report earnings of 58 cents per share on revenue of $2.83 billion before the opening bell.</li>
<li>Delta Air Lines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) was 0.24% lower as it is expected to report earnings before the market opens. Analysts estimate earnings of $2.05 per share on revenue of $15.45 billion.</li>
<li>Helen of Troy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) advanced 1.29% as analysts expect it to report earnings of 90 cents per share on revenue of $398.20 million before the opening bell.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.53% to hover around $68.01 per barrel.
Gold Spot US Dollar rose 0.35% to hover around $3,325.28 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.16% at the 97.3950 level.
Asian markets ended mostly higher on Thursday, except India's S&amp;P BSE Sensex and Japan's Nikkei 225 indices. Meanwhile, South Korea's Kospi, Hong Kong's Hang Seng, Australia's ASX 200, and China&#8217;s CSI 300 indices rose. European markets were higher in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46336115/as-trump-calls-for-3-percentage-point-rate-cut-too-late-jerome-powell-to-resign-june-fed-minutes-sh">As Trump Calls For 3-Percentage Point Rate Cut, &#8216;Too Late&#8217; Jerome Powell To Resign, June Fed Minutes Show &#8216;Uncertainty&#8217; Reigns Supreme</a></li>
</ul>
Photo courtesy: godongphoto / Shutterstock.com

Equities

CELZ

HELE

KLTO

NVDA

US Stocks Likely To Open Lower A Day After Nasdaq Hits Record High: Nvidia, Kellogg, Klotho In Focus

HC Wainwright &amp; Co. analyst Brandon Folkes initiates coverage on ANI Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIP#NASDAQ">ANIP</a>) with a Buy rating and announces Price Target of $84.

Initiation

ANIP

HC Wainwright & Co. Initiates Coverage On ANI Pharmaceuticals with Buy Rating, Announces Price Target of $84

Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) has announced a <a target="_blank" href="https://static.nhtsa.gov/odi/rcl/2025/RCLRPT-25V455-7716.pdf" rel="noreferrer noopener">recall</a> of more than 850,000 vehicles in the U.S. due to a faulty fuel system component that may cause engines to stall while driving. The recall affects 11 models, including the Lincoln Navigator, Ford F-150, Explorer, Mustang, and various Super Duty trucks manufactured between July 2021 and July 2022.
The issue stems from a low-pressure fuel pump in the fuel delivery module, which can fail due to internal contamination and tight component clearances. This failure can lead to a sudden loss of fuel pressure and engine shutdown, especially under low fuel or high-temperature conditions. Drivers might notice signs such as rough idling, reduced power, or a check engine light before a failure occurs.
As of June, Ford had received nearly 1,900 warranty claims and over 80 related field and customer service reports. No accidents or injuries have been reported. The company is developing a fix and will begin mailing notices to vehicle owners in mid-July.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/07/46291379/nhtsa-launches-probe-into-stellantis-owned-ram-pickup-truck-recall-after-reports-of-injuries" target="_blank" rel="noreferrer noopener">NHTSA Launches Probe Into Stellantis-Owned RAM Pickup Truck Recall After Reports Of Injuries</a>
The defective component was supplied by Phinia Inc., based in Chihuahua, Mexico. Ford linked the problem to changes made in the supplier&#8217;s manufacturing process, which increased the risk of fuel pump friction and vapor lock. An investigation into the issue began in 2022.
This latest action adds to Ford&#8217;s growing list of vehicle safety challenges. Just weeks ago, the automaker also initiated a recall of Lincoln Aviator SUVs due to an adhesive flaw, another sign of <a href="https://www.benzinga.com/markets/tech/25/06/46068633/ford-recalls-aviator-suvs-as-adhesive-issue-adds-to-automakers-mounting-recall-woes" target="_blank" rel="noreferrer noopener">mounting recall woes</a> at the company.
Last week, Ford Motor <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46213625/ford-sales-surge-14-2-in-q2-beating-market-estimates-but-ev-sales-decline-31" rel="noreferrer noopener">reported</a> its second-quarter U.S. sales rose 14.2% to 612,095 vehicles, led by strong F-Series pickup demand. The company sold 222,459 F-Series trucks, up 11.5% year over year, and 156,509 electrified vehicles year to date, a 14.7% increase. EV sales declined 31.4% from a year ago to 16,438 units.
Related ETFs: SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), Global X Autonomous &amp; Electric Vehicles ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIV#NASDAQ">DRIV</a>).
Price Action: At the last check on Thursday, F shares were trading lower by 0.085% to $11.82 premarket.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46337340/elon-musk-says-tesla-will-expand-robotaxi-services-to-san-francisco-bay-area-in-a-month-or-two" target="_blank" rel="noreferrer noopener">Elon Musk Says Tesla Will Expand Robotaxi Services To San Francisco Bay Area &#8216;In A Month Or Two&#8217;</a></li>
</ul>
Image Via Shutterstock

Large Cap

Tech

DRIV

Ford Recalls Over 850,000 Vehicles Due To Stalling Engines

Biotech

Health Care

Financing

Offerings

RYTM

Rhythm Pharmaceuticals Prices Its Upsized Public Offering Of 2.06M Shares At $85/Share, With Gross Proceeds Of Approximately $175M

HC Wainwright &amp; Co. analyst Emily Bodnar maintains RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) with a Buy and raises the price target from $6 to $27.

RAPT

HC Wainwright & Co. Maintains Buy on RAPT Therapeutics, Raises Price Target to $27

<ul>
<li>The new network will allow Cuenta Nómina customers to withdraw cash without fees at more than 740 new ATMs throughout Spain.</li>
<li>The expansion is the result of an alliance with NCR Atleos, a provider specializing in financial self-service solutions.</li>
</ul>

ING Continues Its Growth In Spain By Expanding Services For Its More Than 4.4M Customers, Through More Than 740 New NCR Atleos Terminals, Its Customers Of "Cuenta Nómina" Will Be Able To Withdraw Cash Without Fees

HC Wainwright &amp; Co. analyst Heiko Ihle maintains First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and raises the price target from $11.5 to $12.75.

HC Wainwright & Co. Maintains Buy on First Majestic Silver, Raises Price Target to $12.75

HSBC analyst Frank Lee upgrades Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) from Hold to Buy and announces $200 price target.

HSBC Upgrades Advanced Micro Devices to Buy, Announces $200 Price Target

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MREO#NASDAQ">MREO</a>) with a Buy and lowers the price target from $7 to $5.

MREO

Needham Maintains Buy on Mereo BioPharma Group, Lowers Price Target to $5

<a href="https://x.com/elonmusk/status/1943251229511160001" title="https://x.com/elonmusk/status/1943251229511160001">https://x.com/elonmusk/status/1943251229511160001</a>

TSLA

Elon Musk Post on X: Grok is coming to Tesla vehicles very soon. Next week at the latest.

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) announced its <a target="_blank" href="https://www.benzinga.com/topic/tsmc" rel="noreferrer noopener">net revenue</a> for June 2025 on Thursday.
The leading contract chipmaker reported consolidated revenue of approximately 263.71 billion New Taiwan dollars (approximately $8.3 billion) for the month. This represents a 17.7% decrease from May 2025 but a 26.9% increase <a target="_blank" href="https://pr.tsmc.com/english/news/3246" rel="noreferrer noopener">compared to June 2024</a>.
For the first half of 2025 (January through June), Taiwan Semiconductor&#8217;s total revenue reached 1.773 trillion New Taiwan dollars (approximately $55.8 billion), marking a 40.0% year-over-year increase.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46219423/taiwan-semiconductor-outperforming-the-market-shows-moatbut-it-comes-with-risk" rel="noreferrer noopener">Taiwan Semiconductor Outperforming The Market Shows Moat, But It Comes With Risk</a>
Taiwan Semiconductor&#8217;s <a target="_blank" href="https://www.benzinga.com/25/04/44732800/taiwan-semiconductor-reports-255-billion-q1-revenue-surges-42-in-despite-us-tensions" rel="noreferrer noopener">second-quarter 2025 revenue</a> reached 933.79 billion New Taiwan dollars (approximately 31.9 billion), based on the reported first−quarter revenue of 839.25 billion New Taiwan dollars ($25.5 billion). This indicates a strong 38.6% year-over-year growth for the second quarter of 2025, topping the company&#8217;s own guidance of $28.4 billion to $29.2 billion issued in April.
Bloomberg analyst Charles Shum <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-07-10/tsmc-revenue-climbs-39-in-latest-sign-of-ai-spending-boom?sref=TBDibEcD" rel="noreferrer noopener">attributed</a> this performance to robust AI-driven demand from chip designers like Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and increasing outsourcing orders from Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>). Shum suggests this strong momentum is offsetting softness in the mobile and consumer segments, helping Taiwan Semiconductor remain on track for its 25% annual U.S. dollar sales-growth target. However, he anticipates operating margins may be closer to the lower end of guidance (around 47%) due to the weakening U.S. dollar.
In a related development, Taiwan Semiconductor is reportedly prioritizing its <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46283410/taiwan-semiconductor-shifts-focus-100-billion-usa-expansion" rel="noreferrer noopener">U.S. expansion</a>, accelerating American operations in response to potential chip import tariffs from Washington. This focus has reportedly led to the postponement of a second planned Japanese plant, despite a $20 billion investment plan and $8 billion in pledged support from the Japanese government.
While Chairman C.C. Wei previously cited traffic issues in Kumamoto for early delays, sources suggest the project&#8217;s resumption in Japan is not imminent. In March, Taiwan Semiconductor announced an additional $100 billion investment in U.S. chipmaking, building on the $65 billion announced in April 2024.
Taiwan Semiconductor stock has surged over 17% year-to-date, topping NYSE Composite&#8217;s 8% and PHLX Semiconductor&#8217;s approximately 14%. The stock surged over 53% in the last three months, topping NYSE Composite&#8217;s 12% and PHLX Semiconductor&#8217;s 34%.
Price Action:&nbsp;TSM stock is trading higher by 1.66% to $235.70 premarket at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46295574/nvidia-outpaces-market-with-ai-powered-growth" target="_blank" rel="noreferrer noopener">Nvidia Outpaces Market With AI-Powered Growth, Nears Record Highs</a></li>
</ul>
Photo via Shutterstock

Media

INTC

Taiwan Semiconductor Reports Solid Half-Year Revenue, June Sees Monthly Decline

Press Releases

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Management

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

Comments

Corbus Pharmaceuticals

Corbus Pharmaceuticals (CRBP) Options

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL